| ETAGX | FSMAX | ETAGX / FSMAX | |
| Total Expense Ratio | 1.43 | 0.04 | 4,086% |
| Annual Report Gross Expense Ratio | 1.43 | 0.04 | 4,086% |
| Fund Existence | 16 years | 14 years | - |
| Gain YTD | 11.228 | 13.303 | 84% |
| Front Load | 6% | N/A | - |
| Min. Initial Investment | 1000 | 0 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 2.97B | 41B | 7% |
| Annual Yield % from dividends | 0.00 | 0.43 | - |
| Returns for 1 year | 8.36 | 10.55 | 79% |
| Returns for 3 years | 36.16 | 67.63 | 53% |
| Returns for 5 years | -14.60 | 26.24 | -56% |
| Returns for 10 years | 113.43 | 118.30 | 96% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| PDECX | 17.68 | 0.11 | +0.63% |
| PGIM Jennison Emerging Markets Eq Opps C | |||
| NWHQX | 32.38 | 0.10 | +0.31% |
| Nationwide Bailard Tech & Sci M | |||
| AZMIX | 20.00 | 0.05 | +0.25% |
| Virtus NFJ Emerging Markets Value Ins | |||
| NWABX | 28.03 | 0.03 | +0.11% |
| Nationwide R6 | |||
| SHSSX | 71.14 | -0.03 | -0.04% |
| BlackRock Health Sciences Opps Instl | |||